Introduction
Stroke is one the leading causes of death in the world and a common cause of disability [1, 2] . Ischemic stroke (IS) is a multifactorial, polygenic, complex disease resulting from the combination of vascular, environmental and genetic factors [3] . Inflammation and genetics are both prominent mechanisms in the pathogenesis of IS [4] . Candidate genes, stroke-susceptible alleles and their association with stroke pathogenesis have been intensely studied in the last few years [5] [6] [7] . Tumor necrosis factor-α (TNF-α) is a pleiotropic proinflammatory cytokine which is mainly produced by macrophages, lymphocytes, natural killer cells and neurons [8] . The human TNF-α gene is located on chromosome 6p21.3, which consists of 4 small exons and encodes a protein of 233 amino acid residues.
TNF-α is known to play a significant role in the recruitment of leukocytes from the circulation, and therefore is a crucial determinant of inflammatory reaction in stroke [9, 10] . TNF-α is also considered as a strongly deleterious cytokine in stroke and is involved in the expansion of brain infarcts. On the other hand, there is a suggestion that TNF-α may also play a neuroprotective role in stroke through downregulation of apoptosis [11, 12] . Genetic screening of the TNF-α gene has revealed -238G/A and -308G/A polymorphic regions in the promoter region of TNF-α, which has been associated with high TNF-α production. The increased level of TNF-α has severe effects on lipid metabolism, coagulation and endothelial function, which may contribute to the risk of IS [13, 14] . However, a higher level of TNF-α might be expected to be associated with increased stroke risk, but some epidemiological evidence is of no significance.
Previous studies examining the association between TNF-α -238G/A and -308G/A gene polymorphisms and IS showed inconclusive and contradictory results. Therefore, we performed a meta-analysis on all the published case-control studies to assess the association of TNF-α -238G/A and -308G/A gene polymorphisms with the risk of IS.
Materials and Methods

Identification of Relevant Studies
A literature search for eligible candidate gene studies published before April 20, 2015 , was conducted in the PubMed, Medline, EMBASE and Google Scholar databases. To avoid subjectivity in the choice of the time point, we fixed April 20, 2015, as the cutoff date for the inclusion of new studies. The following combinations of main keywords were used: ('tumor necrosis factor-alpha' or 'TNF-α') and ('ischemic stroke' or 'cerebral infarction' or 'IS') and ('genetic polymorphism' or 'single nucleotide polymorphisms' or 'SNP'). The search was done without language restriction, but only included those studies that were conducted on human subjects. All references in eligible articles were extensively reviewed to identify additional published articles. Pooled odds ratios (OR) and 95% confidence intervals (CI) were determined for TNF-α gene-disease association. The meta-analysis was carried out using RevMan 5.3 software.
Inclusion and Exclusion Criteria
To be included in the analysis, eligible studies had to meet the following criteria: (1) case-control studies on the association between the TNF-α -238G/A or -308G/A gene polymorphisms and susceptibility to IS; (2) all patients in the candidate studies meeting the diagnostic criteria for IS, and (3) studies with sufficient available data to calculate ORs with corresponding 95% CI. The major reasons for excluding studies were:
(1) not a case-control study; (2) duplicate publications with overlapping subjects from the same study, and (3) no available data reported. This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guideline [15] . No author was contacted regarding the missing information that was required for the meta-analysis to avoid the risk of retrieval bias [16] .
Data Extraction
According to the PRISMA guidance, 2 investigators (P.K. and S.M.) independently checked each full-text report for eligibility and extracted the following data from eligible studies: surname of the first author, year of publication, country of origin, ethnicity, definition and number of cases and controls, age, sex ratio, genotyping method and genotype frequency, etc. Disagreements were solved by discussion between all authors until a consensus was reached.
Quality Assessment
We also evaluated the methodological quality of every study included in our analysis using a quality assessment scale developed for genetic association studies [17] , which was modified by us to increase the relevance of our study. This scale took into account both traditional epidemiological considerations and genetic issues. The scores ranged from 0 (worst) to 16 (best). Details of the scale are presented in table 1 . Two authors independently assessed the quality of the included studies. Discrepancies over quality scores were resolved by discussion with all authors and subsequent consensus.
Statistical Analysis
Genotype distributions in the controls were tested for agreement with the Hardy-Weinberg equilibrium (HWE) using the χ 2 test. The association between the TNF-α genetic polymorphisms and susceptibility to IS was assessed by pooled ORs with their corresponding 95% CI under three genetic models: dominant, recessive and co-dominant. Taking into consideration possible heterogeneity between studies, a statistical test for heterogeneity was first conducted using Cochran's Q statistics and I 2 metrics [18] . We considered the presence of significant heterogeneity at the 10% level of significance and values of I 2 exceeding 50% as an indicator of significant heterogeneity. When no heterogeneity was found with p < 0.10 or I 2 , 50%, a fixedeffect model was used to estimate the pooled ORs and 95% CI. Otherwise, a random-effect model was applied. In addition to an overall comparison, stratified analyses based on ethnicity were used to investigate whether overall reported associations were present in subgroups. Begg's funnel plot was used to assess the potential for publication bias. 
Results
A total of 67 published articles were identified using the prespecified search strategy. Figure 1 represents a flow chart of retrieved and excluded studies with their reasons for exclusion. Out of the 67 retrieved articles, 34 studies were excluded due to their irrelevance to our interest; 11 studies were excluded as they were in duplicate, and 4 studies were excluded as they did not show an association with IS. Finally, a total 18 of studies were included in this meta-analysis. 
Association of TNF-α -238G/A Gene Polymorphism with Susceptibility to IS
Seven case-control studies with a total of 1,846 IS patients and 1,905 controls also showed a significant association with susceptibility to IS under a dominant model (AA + GA vs. GG: OR, 1.40; 95% CI, 1.11-1.76; p = 0.004). Studies were conducted in two major ethnic populations; 5 studies were in Asian and 2 studies in Caucasian populations. Four studies in this meta-analysis had controls in HWE. Six studies had population-based controls and 1 study had hospital-based controls. The quality scores of all included studies were moderately high. The characteristics and methodological quality of all included studies are summarized in table 2 .
Based on ethnicity stratification analysis, a significant association was observed in Caucasian studies (OR, 1.76; 95% CI, 1.26-2.47; p = 0.0009), but a nonsignificant association was observed (OR, 1.13; 95% CI, 0.82-1.55; p = 0.45) in Asian studies under a dominant model ( fig. 2 ). Begg's funnel plots were used to assess the potential for publication bias of the included studies under a dominant model. The shapes of the funnel plots suggest a significant publication bias ( fig. 3 ) .
Association of TNF-α -308G/A Gene Polymorphism with Susceptibility to IS
Sixteen case-control studies were included in this meta-analysis with a total of 5,651 IS patients and 5,792 controls. Studies were conducted in two major ethnic populations; 9 studies were conducted in Asian and 5 in Caucasian populations. The publication years of the included studies ranged from 2004 to 2014. Twelve studies in this meta-analysis had controls in HWE. Twelve studies had population-based controls and 4 studies had hospital-based fig. 4 ). Begg's funnel plots were used to assess the potential for publication bias of the included studies under a dominant model. The shapes of the funnel plots suggest a significant publication bias ( fig. 5 ).
Discussion
According to the results of the present meta-analysis, TNF-α -238G/A polymorphism increases the risk of IS, but TNF-α -308G/A polymorphism appears to protect against IS. However, a recessive model of Caucasian studies involving 1,449 cases and 1,767 controls suggests that the -308G/A variant might be a risk factor for IS. In the subgroup analysis by ethnicity, a more significant increased risk of IS was found in Caucasian studies as compared to Asian studies for -238G/A TNF-α gene polymorphism. Based on ethnicity stratification, varying results were obtained, which may be due to different genetic regions and environments having different religions, languages and customs. The differences in the genetic backgrounds of smoking, alcohol intake, diet, infection, congenital or acquired heart disease, and metabolic and hematological disorders may represent risk factors for IS. The protective nature of TNF-α -308 G/A gene polymorphisms may be due to the modest effect played by this molecular gene variant along with the notion of a multifactorial and polygenic etiology of IS, where each genetic determinant plays a small contributory role. We included all the recently published studies to extract more evidence and draw a precise conclusion for the association between TNF-α gene polymorphisms and the risk of IS. Our findings are in accordance with the previously published meta-analyses by Gu et al. [18] for -238G/A polymorphism and Gu et al. [19] and Pereira et al. [20] for -308G/A polymorphism. Various genome-wide association studies (GWAS) for stroke have been published [36] [37] [38] [39] [40] [41] , but most of these study populations were of Caucasian origin, and they did not detect the association of TNF-α -238G/A and -308G/A polymorphisms in the TNF-α gene with stroke. Indeed, similar negative results were obtained from the European populations reported by Freilinger et al. [42] . Recently, due to the small sample size in stage 1 of GWAS screening (131 cases and 135 controls), the GWAS performed in the Japanese population [39] did not have a sufficient power to observe a positive association.
The present meta-analysis must be interpreted with caution because of certain limitations. First, the studies included in this meta-analysis varied in ethnicity, age and environmental factors. Second, the use of different methodologies for the genotyping method, selection of controls and matching criteria may have led to heterogeneity. Third, not all other variants (-857C/T, -863C/A, -1031T/C) located in the human TNF-α promoter gene were assessed in this study. Complete sequencing will be necessary for systematic identification of potentially causative mutations in the TNF-α whole-gene function region. In addition, genetic tests are needed to assess the clinical utility of drugs and doses routinely used to treat patients with stroke or at risk of stroke. The protective nature of TNF-α gene polymorphism may be beneficial to patients based on genotyping and functional assay of the whole TNF-α promoter gene. Finding a link between inflammatory genetic markers and cerebrovascular events will certainly require a careful study of well-characterized and phenotypically homogeneous subjects as well as meticulous analyses of gene-gene and gene-environment interactions by prospective studies. The prospective design will be important not only to avoid survival bias, but also to address issues underexplored thus far, such as age at stroke. Also, additional approaches such as haplotypic analysis with markers in the vicinity of TNF-α may provide more informative and useful data for the study of the genetic etiology of cerebrovascular diseases than single-genotype-based data. In summary, the present meta-analysis shows a protective effect of TNF-α -308G/A gene polymorphism on IS risk, but a significant association was observed between TNF-α -238G/A gene polymorphism and the risk of IS. However, TNF-α -308G/A gene polymorphism might be associated with IS as observed in the recessive model of the Caucasian population. More credible evidence is required to draw solid conclusions on the association between TNF-α -238G/A and -308G/A gene polymorphisms and the risk of IS.
Conclusion
Our meta-analysis shows that TNF-α -238G/A gene polymorphism is more likely to be associated with the risk of IS in Caucasian populations than in Asian populations. However, TNF-α -308G/A gene polymorphism is more likely to be protective against IS in Asian populations as compared to Caucasian populations. Further large, prospective, epidemiological studies are needed to confirm these findings.
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